Successful recovery with venovenous ECMO for ARDS after LVAD HeartMate 3 implantation: A case report
Authors:
- 1 June 2022
- journal article
- editorial
- Published by Hindawi Limited in Journal of Cardiac Surgery
- Vol. 37 (8) , 2450-2452
Abstract
Acute respiratory distress syndrome (ARDS) following left ventricular assist device (LVAD) implantation is a rare complication. Venovenous (VV) extracorporeal membrane oxygenation (ECMO) is used as a treatment for severe ARDS and pneumonia. We report the successful use of VV ECMO for ARDS Klebsiella pneumonia following urgent LVAD HeartMate 3 implantation.Keywords
This publication has 4 references indexed in Scilit:
- Clinical Implications of Respiratory Failure in Patients Receiving Durable Left Ventricular Assist Devices for End-Stage Heart FailureCirculation: Heart Failure, 2019
- Positive Pressure Ventilation in the Cardiac Intensive Care UnitJACC, 2018
- Eighth annual INTERMACS report: Special focus on framing the impact of adverse eventsThe Journal of Heart and Lung Transplantation, 2017
- Management of Refractory Hypoxemia During Venovenous Extracorporeal Membrane Oxygenation for ARDSASAIO Journal, 2015